Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

<ul>
<li>There could be 2 changes for the <a href="https://www.smartkarma.com/entities/hang-seng-china-enterprises-index" target="_blank" data-smartkarma-citation="entities:22900:1" rel="noopener">Hang Seng China Enterprises Index (HSCEI INDEX)</a> in March. Announcement is on 13 February with implementation at the close on 5 March.</li>
<li>The forecast adds have outperformed the forecast deletes and the index over the last couple of months and there could be more upside over the near-term.</li>
<li>Estimated one-way turnover at the rebalance is 1.8% resulting in a round-trip trade of HK$2.3bn. There is more than 1x ADV to trade in a few stocks.</li>
</ul>


There could be 2 changes for the Hang Seng China Enterprises Index (HSCEI INDEX) in March. Announcement is on 13 February with implementation at the close on 5 March.
The forecast adds have outperformed the forecast deletes and the index over the last couple of months and there could be more upside over the near-term.
Estimated one-way turnover at the rebalance is 1.8% resulting in a round-trip trade of HK$2.3bn. There is more than 1x ADV to trade in a few stocks.


HSCEI Index Rebalance Preview: 2 Sets of Changes Likely in March

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analysed the earning revision of component stocks of HSCEI in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on XIAOMI, INNOVENT BIOLOGICS, YUM CHINA, CCB, LI AUTO, CNOOC, MEITUAN, CNOOC, Yum China, Meituan, CCB, Xiaomi, Innovent Bio, Li Auto.</li>
</ul>


We analysed the earning revision of component stocks of HSCEI in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on XIAOMI, INNOVENT BIOLOGICS, YUM CHINA, CCB, LI AUTO, CNOOC, MEITUAN, CNOOC, Yum China, Meituan, CCB, Xiaomi, Innovent Bio, Li Auto.


HSCEI Index Earning Revision (Dec): XIAOMI, INNOVENT BIOLOGICS, YUM CHINA, CCB, LI AUTO, CNOOC

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

China Shengmu Organic Milk / Event-Driven

<ul>
<li>On the 30th October, <strong><a href="https://www.smartkarma.com/entities/china-modern-dairy-holdings" target="_blank" data-smartkarma-citation="entities:6785:1" rel="noopener">China Modern Dairy (1117 HK)</a></strong> (CMD) entered into a conditional SPA to acquire a 1.28% stake in raw milk producer <strong><a href="https://www.smartkarma.com/entities/china-shengmu-organic-milk" target="_blank" data-smartkarma-citation="entities:12714:1" rel="noopener">China Shengmu Organic Milk (1432 HK)</a></strong> (CSM). </li>
<li>CMD currently holds 29.99% in CSM. Should the SPA complete, CMD clears 30% and will be obligated to make an Offer for all shares not held. </li>
<li>The Offer Price will be A$0.35/share, a 14.75% premium to undisturbed. The Offer will be conditional on a 50% acceptance hurdle. </li>
</ul>


On the 30th October, China Modern Dairy (1117 HK) (CMD) entered into a conditional SPA to acquire a 1.28% stake in raw milk producer China Shengmu Organic Milk (1432 HK) (CSM). 
CMD currently holds 29.99% in CSM. Should the SPA complete, CMD clears 30% and will be obligated to make an Offer for all shares not held. 
The Offer Price will be A$0.35/share, a 14.75% premium to undisturbed. The Offer will be conditional on a 50% acceptance hurdle. 


On China Shengmu (1432)'s Conditional MGO

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of December 12th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight flows for Xiaomi, Tencent, CMB, Alibaba, Zhejiang Leapmotor Technology, BYD.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of December 12th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight flows for Xiaomi, Tencent, CMB, Alibaba, Zhejiang Leapmotor Technology, BYD.


HK Connect Flows Weekly (Dec 12th): Xiaomi Inflows & Tencent/Alibaba Outflows

HK/China Equity Long-Short

Osbert Tang, CFA

Equity Bottom-Up

<ul>
<li>After a tragic 61.4pp underperformance against the HSI in 2025, the market is almost unanimously bearish on <a href="https://www.smartkarma.com/entities/meituan" target="_blank" data-smartkarma-citation="entities:26970:1" rel="noopener">Meituan (3690 HK)</a>, which presents opportunities in 2026.</li>
<li>Negative news did not push it further down; P/B is at over 1SD below average, and net cash-to-share price is 5.6pp above the historical average.</li>
<li>3Q25 margins are so depressed that sustaining the price war is difficult. As the 7th-heaviest HSI constituent, it is the one to move the Index next year. </li>
</ul>


After a tragic 61.4pp underperformance against the HSI in 2025, the market is almost unanimously bearish on Meituan (3690 HK), which presents opportunities in 2026.
Negative news did not push it further down; P/B is at over 1SD below average, and net cash-to-share price is 5.6pp above the historical average.
3Q25 margins are so depressed that sustaining the price war is difficult. As the 7th-heaviest HSI constituent, it is the one to move the Index next year. 


2026 High Conviction: Meituan (3690 HK) - Contrarian Perspectives

Hong Kong

Mengniu Dairy is a leading Chinese dairy enterprise focused on manufacturing and distributing a wide range of nutritious, healthy, and delicious dairy products. Its product portfolio includes liquid milk, ice cream, milk powder, and cheese. The company is headquartered in Hohhot, Inner Mongolia, China, and was founded in 1999.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mengniu Dairy (2319 HK)

HSCEI Index Rebalance Preview: 2 Sets of Changes Likely in March

There could be 2 changes for the HSCEI in March. Estimated turnover is 1.8% and round-trip trade is HK$2.3bn. KE Holdings could potentially be...

Brian Freitas

HSCEI Index Earning Revision (Dec): XIAOMI, INNOVENT BIOLOGICS, YUM CHINA, CCB, LI AUTO, CNOOC

We analyzed HSCEI's consensus for Dec 2025 and highlighted changes of EPS in XIAOMI (1810 HK), INNOVENT BIOLOGICS (1801 HK), YUM CHINA (9987 HK),...

Ke Yan, CFA, FRM

On China Shengmu (1432)'s Conditional MGO

China Modern (117 HK) (CMD)'s conditional SPA to acquire 1.28% in China Shengmu Organic Milk (1432 HK) (CSM), requires CMD independent shareholder...

David Blennerhassett

HK Connect Flows Weekly (Dec 12th): Xiaomi Inflows & Tencent/Alibaba Outflows

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Tencent, CMB, Alibaba, Zhejiang Leapmotor...

Ke Yan, CFA, FRM

2026 High Conviction: Meituan (3690 HK) - Contrarian Perspectives

The market's unanimous bearish stance on Meituan creates opportunities in 2026, given its low P/B and high net cash-to-share price. Margins are so...

Osbert Tang, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)